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Summary
Bariatric surgery is an effective therapy for obesity but is associated with long-term complications such as dumping 
syndromes and nutritional deficiencies. We report a case of a 26-year-old caucasian female, with history of morbid obesity 
and gestational diabetes (GDM), who became pregnant 4 months after Roux-en-Y bypass surgery. She developed GDM 
during subsequent pregnancy, which was initially managed with metformin and insulin. Nocturnal hypoglycaemia causing 
sleep disturbance and daytime somnolence occured at 19 weeks of pregnancy (19/40). Treatment with rapid-acting 
carbohydrates precipitated further hypoglycaemia. Laboratory investigations confirmed hypoglycaemia at 2.2 mmol/L 
with appropriately low insulin and C-peptide, intact HPA axis and negative IgG insulin antibodies. The patient was seen 
regularly by the bariatric dietetic team but concerns about compliance persisted. A FreeStyle Libre system was used from 
21/40 enabling the patient a real-time feedback of changes in interstitial glucose following high or low GI index food 
intake. The patient declined a trial of acarbose but consented to an intraveneous dextrose infusion overnight resulting 
in improvement but not complete abolishment of nocturnal hypoglycaemia. Hypoglycaemias subsided at 34/40 and 
metformin and insulin had to be re-introduced due to high post-prandial blood glucose readings. An emergency C-section 
was indicated at 35 + 1/40 and a small-for-gestational-age female was delivered. There have been no further episodes of 
hypoglycaemia following delivery. This case illustrates challenges in the management of pregnancy following bariatric 
surgery. To our knowledge, this is the first use of FreeStyle Libre in dumping syndrome in pregnancy following bariatric 
surgery with troublesome nocturnal hypoglycaemia.
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 • Bariatric surgery represents the most effective treatment modality in cases of severe obesity. With increasing prevalence 
of obesity, more people are likely to undergo bariatric procedures, many of which are women of childbearing age.
 • Fertility generally improves after bariatric surgery due to weight reduction, but pregnancy is not recommended 
for at least 12–24 months after surgery. If pregnancy occurs, there are currently little evidence-based guidelines 
available on how to manage complications such as dumping syndromes or gestational diabetes (GDM) in women 
with history of bariatric surgery.
 • Diagnosis of GDM relies on the use of a 75 g oral glucose tolerance test (OGTT). The use of this test in pregnant 
women is not recommended due to its potential to precipitate dumping syndrome. Capillary glucose monitoring 
profiles or continuous glucose monitoring (CGM) is being currently discussed as alternative testing modalities.
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Bariatric surgery represents a very effective method in the 
treatment of morbid obesity and related complications. 
Bariatric procedures induce major changes in the structure 
and function of the gastrointestinal tract leading to 
increased propensity to early and late dumping syndromes 
(DS) and nutritional deficiencies (1). The latest UK 
national bariatric surgery registry from 2014 reports that 
from 12 869 women who had bariatric surgery between 
2011 and 2013, nearly 70% were of childbearing age (2), 
and these numbers are likely to rise since the prevalence 
of obesity increases. Fertility improves following bariatric 
surgery due to improved ovulation rates linked with weight 
loss; however, women are advised to avoid pregnancy 
for 12–24  months after bariatric intervention to reduce 
the risk of intrauterine growth retardation caused by the 
ongoing catabolic state (3). To our knowledge, data on 
pregnancy numbers after bariatric surgery in the UK are 
currently not available.
Pregnancy constitutes a state of increased insulin 
resistance. Gestational diabetes mellitus (GDM) is defined 
as diabetes diagnosed during the second or third trimester 
of pregnancy that was not clearly overt prior to gestation. 
It is linked with an increased risk of adverse outcomes for 
the mother and for the baby (4). A significant proportion 
of women who had bariatric intervention, despite having 
lost significant amount of weight, would still have a 
body mass index (BMI) >30 kg/m2 at the time of booking 
appointment or would have had previous history of GDM 
thus fulfilling the current National Institute for Health 
and Care Excellence (NICE) criteria for GDM screening 
(5). A standard screening and diagnostic test for GDM, the 
75 g 2-h oral glucose tolerance test (OGTT) is considered 
to be risky in patients after bariatric surgery due to its 
potential to cause DS as a result of altered glycaemic 
responses. Alternative approaches such as capillary 
glucose monitoring or the use of continuous glucose 
monitoring (CGM) are currently being debated (6). In 
addition, once diagnosed, GDM in women after bariatric 
surgery constitutes a challenging clinical condition 
requiring multidisciplinary management with surgical, 
medical, obstetric and dietetic input with currently little 
evidence-based guidelines available (3).
FreeStyle Libre Flash glucose monitoring system (FL) 
(Abbott Diabetes Care, Maidenhead, UK) represents a 
variation of CGM that has been recently introduced into 
clinical practice. It consists of a sensor that measures 
interstitial glucose (IG) levels at closed spaced intervals 
with a storage capacity of 8 h of IG data and of a reader 
with a monitor. In order to get a coherent IG profile, the 
user is asked to swipe the reader over the sensor at least 
every 8 h. IG data are displayed on the monitor of the 
reader together with IG trends. FL thus provides a useful 
and less costly alternative to standard CGM despite its 
recognised limitations such as inability to set alarms 
for high or low IG levels and a recognised tendency to 
lower-than-expected IG values in lower glucose ranges 
compared to the reference method (7).
Case presentation
A 26-year-old Caucasian female with history of morbid 
obesity (pre-surgery BMI 44.3 kg/m2) and GDM in her 
two previous pregnancies underwent Roux-en-Y gastric 
bypass (RYGB) surgery and became pregnant four months 
later. The patient had a background of polycystic ovarian 
syndrome, endometriosis, laparoscopic right ovarian 
cystectomy, appendectomy and vitamin D deficiency. 
She also developed mild cholestasis of pregnancy and 
was treated with ursodeoxycholic acid. There was also 
a history of complex social circumstances and domestic 
abuse. There was no family history of obesity, diabetes, 
GDM or any other endocrine condition in her first-degree 
relatives. Her brother and grandfather from mother’s side 
had a history of lung emphysema. She has received the 
standard dietary education and counselling provided 
by the bariatric dietician team for people undergoing 
bariatric interventions at Sheffield Teaching Hospitals 
NHS Foundation Trust before and subsequently after 
her bariatric surgery. This included provision of detailed 
verbal and written information regarding necessary 
 • As the CGM technology becomes more available, including the recently introduced FreeStyle Libre Flash 
glucose monitoring system, more pregnant women, including those after bariatric surgery, will have access to 
this technology. We suggest urgent development of guidelines regarding the use of CGM and flash glucose 
monitoring tools in these circumstances and in the interim recommend careful consideration of their use on a 
case-to-case basis.
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dietary modifications, vitamin and micronutrient 
supplementation together with the recommendation of 
avoiding pregnancy for 12–24 months after the bariatric 
surgery. During the course of pregnancy, she has been 
taking vitamin and micronutrient supplementation 
(WLS Forte and Calcium Plus, FitForMe, Rotterdam, 
Netherlands) and in addition, a cholecalciferol 800 IU 
tablet per day.
As expected, she continued to lose weight in the 
months following the bariatric surgery, which continued 
during the course of pregnancy (Fig. 1).
Due to the previous history of GDM and bariatric 
surgery, the patient was offered capillary blood glucose 
monitoring at her booking appointment at 11th week of 
gestation (11/40), instead of the usual 2-h 75 g OGTT test. 
The recorded blood glucose (BM) values were diagnostic 
of GDM (6) (Table  1A) and metformin was started at 
15/40. BM values continued to be elevated on metformin 
(Table  1B), and insulin (Humulin I and Humalog (Eli 
Lilly)) was added 2 weeks later.
At 19/40, this lady was admitted under the care of 
the Obstetrics and Gynaecology team with persistent 
vomiting. A week prior to admission (18/40), she began 
to record BM readings in the hypoglycaemic range that 
were symptomatic, with a tremor and increased sweating. 
Metformin and insulin were stopped at 19/40, but the 
post-prandial and nocturnal hypoglycaemia persisted. 
She had no history of chronic liver disease, and her liver 
function tests were normal apart from a mild elevation of 
bile acids in the range of 20–37 µmol/L (reference range 
(RR): 0–14 µmol/L) throughout the 3rd trimester of her 
pregnancy in keeping with the diagnosis of cholestasis of 
pregnancy. Her renal function was normal.
Investigation
Laboratory investigations showed a blood glucose value 
of 2.2 mmol/L with appropriately low insulin levels 
(14.8 pmol/L,RR: 17.8–173 pmol/L) and C-peptide levels 
(113 pmol/L, RR: 298–2350 pmol/L), negative IgG insulin 
antibodies and 09:00 h cortisol value of 658 nmol/L, 
indicating an intact hypothalamic–pituitary–adrenal axis.
Treatment
Diagnosis of late DS, most likely in combination with 
an early dumping phase, was established, and this lady 
received appropriate dietary advice from the bariatric 
dietetic team. She was advised to take frequent small-
portioned meals, with the exclusion of high glycaemic 
index (GI) food and a preference for low GI food. Avoidance 
of liquid carbohydrates and drinking fluids with meals 
(1, 3) was recommended. She found it difficult to adhere 
to dietary recommendations and treated hypoglycaemia 
with fast-acting carbohydrates resulting in subsequent 
hypoglycaemia and disturbed sleep with excess daytime 
tiredness. FL was introduced at 22/40 in order to avoid 
frequent nocturnal finger prick BM measurements and as 
an educational tool with the aim to help the patient to 
identify hypoglycaemic triggers (Fig. 2A).
Despite these measures, this lady continued to 
experience ongoing symptomatic hypoglycaemia that 
she was able to treat independently. Despite very low IG 
and BM readings (finger prick BM readings marked in 
Fig. 2 with *), there was no history of collapse, seizure or 
loss of consciousness. Disturbed sleep continued to have 
negative impact on her wellbeing. At 25/40, a decision 
was made to prevent nocturnal hypoglycaemia with 
continuous intravenous dextrose infusion overnight 
(00:00–07:00 h) (Fig.  2B). Poor compliance with dietary 
recommendations persisted despite ongoing support from 
Figure 1
Weight chart of the 26-year-old lady with history of Roux-en-Y gastric 
bypass surgery who became pregnant shortly after. Times of bariatric 
intervention and approximate time of conception are indicated with 
arrows.
Table 1 Example of capillary blood glucose profiles on diet 














 6.3* 8.4 4.3 8.3 6.3 9.1
 5.4 8.4 5.4 9.5 6.5 10.1
B. On metformin
 6.0 7.2 7.0 9.3 6.3 8.3
 4.2 6.3 5.0 14.3 8.0 10.2
Figures in bold are indicative of gestational diabetes mellitus (GDM).
*All figures are reported in mmol/L.
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the diabetes specialist nurses and bariatric dieticians. The 
patient declined a trial of acarbose due to concerns about 
potential risks to the unborn baby and was resistant to 
the suggestion of discharge with community support. 
This was substantiated by the fear of inability to treat her 
hypoglycaemia when on her own and not being able to 
look after her 2 young children. Gradually, intravenous 
dextrose infusions were discontinued (Fig.  2C), and the 
patient was discharged home at 29/40.
Following discharge, this lady did not attend an 
appointment with the diabetes team and she returned her 
FL device shortly after. She was reviewed in the antenatal 
clinic in later stages of her pregnancy (32/40), and because 
of elevated post-prandial BM values metformin (32/40) 
and later insulin (Humalog) were re-introduced (33/40). 
Hypoglycaemias were less prominent and resolved 
completely at 34/40. The estimated fetal weight (EFW), 
which was on the 50th centile during the earlier stages 
of pregnancy declined at later stages resulting in EFW at 
5th centile at 33/40 (Fig. 3). Head circumference (HC) and 
abdominal circumference (AC) followed a similar trend.
Outcome and follow-up
The patient was readmitted under the care of the 
Obstetrics and Gynaecology team at 34/40 due to reduced 
fetal movements and an emergency caesarean section was 
indicated at 35 + 1/40. She gave birth to a healthy baby 
girl with a birth weight of 2100 g.
After delivery, the patient continued to monitor 
her BMs with finger prick testing, and her BM readings 
remained within the normal range with no further 
occurrence of hypoglycaemia. She was invited for a 
fasting plasma glucose test at 6 weeks postnatally, but did 
not attend to this or any further appointments.
Discussion
RYGB intervention is reported to result in DS in 
approximately 40% of patients, and it has previously 
been suggested that the presence of DS was essential for 
weight reduction, a hypothesis that has been refuted by 
further prospective studies (8). DS is characterised by 
vasomotor and GI symptoms caused by altered gastric 
emptying and subsequent rapid exposure of the small 
intestine to nutrients (1). Early DS is triggered by rapid 
passage of hyperosmolar content into the small bowel 
causing excessive release of GI hormones and shift of 
fluids into the GI lumen. It presents with abdominal pain, 
bloating, diarrhoea and vasomotor symptoms such as 
palpitations, flushing, sweating or tachycardia. Late DS is 
characterised by symptoms of hypoglycaemia and occurs 
typically between 1 and 3 h after meal ingestion (1). Rapid 
gastric emptying leads to expeditious glucose absorption 
Figure 3
Antenatal weight chart. Gestational stage in week is on the X axis, fundal 
height at the left Y axis and estimated weight by scan on the right Y axis.
Figure 2
Interstitial glucose (IG) profiles uploaded from the FreeStyle Libre Flash 
glucose monitoring system. (A) IG profiles with dietary interventions. (B) 
IG profiles with overnight (00:00–07:00 h) i.v. dextrose infusions at 
variable rates as indicated. (C) IG profiles at the time when the patient 
has been gradually weaned off the overnight i.v. dextrose infusions. Line 
in red indicates IG <4 mmol/L. * indicates capillary blood glucose 
measurement.
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from the small bowel leading to initial hyperglycaemia. 
Subsequent peak insulin secretion perpetuated by 
increased glucagon-like peptide 1 levels eventually causes 
hypoglycaemia (1, 9).
The advent of CGM technology enabled observation 
of abnormal glycaemic profiles in non-pregnant women 
after RYGB surgery. These are characterised by early, high 
and short-lasting IG peaks returning back to normal 
values before the usual time points for BM measurements 
after the 75 g OGTT (1 or 2 h post glucose challenge) (10). 
Interestingly, a subsequent study found very similar CGM 
profiles in pregnant women after RYGB (11). The peak 
IG value was reached at 54 ± 9 min and the percentage of 
time spent with IG values above 140 mg/dL (7.8 mmol/L) 
was similar to that observed in women with GDM (11). 
These findings indicate that the standard 75 g OGTT 
test is of poor diagnostic value of GDM in women post 
bariatric surgery. The other concern about the OGTT in 
this population is that the rapid absorption of dextrose 
can precipitate DS as discussed earlier.
Dietary modifications represent the mainstay of 
the management of late DS – patients are advised to 
avoid refined carbohydrates and increase the intake of 
high-GI food, which should be taken in multiple small 
portions throughout the day. Avoidance of drinks taken 
with food and recumbent position whilst eating are 
also recommended (1, 3). If dietary measures are not 
sufficient, use of acarbose, octreotide and diazoxide have 
been reported (1, 3). However, usage of these agents is 
limited by the lack of well-controlled studies examining 
their safety in pregnant women. In refractory cases, 
more invasive measures have been reported – continuous 
enteral feeding or a re-do surgery (1, 3). The patient from 
our report was aware of the paucity of safety data for 
these agents in pregnancy and refused to take any for this 
reason.
In our case, an emergency C-section at 35 + 1/40 
was indicated due to reduced fetal movements and a 
baby girl with a small-for-gestational-age birth weight of 
2100 g was delivered. A large observational study from 
Sweden compared the outcomes of 670 pregnancies 
in women who had undergone bariatric surgery with 
control pregnancies matched for the mother’s pre-surgery 
BMI, age, parity, smoking history, educational level and 
delivery year (12). Pregnancies after bariatric surgery were 
associated with higher risk for small-for-gestational-age 
infants and shorter gestation, but the risk of pre-term 
birth was not significantly different (12). The outcome of 
the pregnancy from our case therefore partially reflects 
these large cohort observations.
We cannot provide a compelling explanation as 
to why this patient’s hypoglycaemic episodes started 
towards the end of the first trimester, neither can we 
explain why they stopped completely in the 34th week 
of her pregnancy, and she has remained asymptomatic 
until the present time. We can presume that pregnancy 
soon after the bariatric intervention contributed to the 
way how her symptoms presented. The pathophysiology 
of DS is not yet fully understood in the non-pregnant 
individuals either (1). We know from clinical observation 
that DS are common after pregnancy and can present 
a real diagnostic and therapeutic challenge (3). Normal 
pregnancy is a state of insulin resistance (IR) that 
gradually increases throughout its course with rising 
plasma insulin concentrations in an attempt to maintain 
normoglycaemia (13). We can therefore hypothesise 
that increased IR in later stages of pregnancy can trigger 
a higher post-prandial insulin secretion leading to 
subsequent hypoglycaemia (late dumping syndrome) 
in pregnant women with history of bariatric surgery, 
but further research will be required to confirm this 
hypothesis. Very recently, case reports of pregnant 
women with history of bariatric surgery suffering from 
dumping syndrome have been reported, and they seem 
to follow a similar time pattern with the occurrence of 
hypoglycaemic symptoms in 24th week of pregnancy 
in both cases (14, 15) and a nearly complete remission 
of symptoms after the delivery in one of the cases (15). 
Authors of the other case report do not comment on the 
presence or absence of symptoms after delivery (14). On 
the other hand, observational studies in pregnant women 
with type 1 diabetes show an increased risk of severe 
hypoglycaemia in 1st trimester and pregnancy-related 
intrinsic factors are postulated to play a role (16). Our 
patient did not experience any hypoglycaemic episodes 
during 1st trimester of her pregnancy, however.
Finally, the indications for the use of FL system 
in our patient were to avoid frequent nocturnal finger 
prick BM measurements that interfered with her sleep 
and as an educational tool with the aim to help her 
to identify hypoglycaemic triggers. The use FL had 
undoubtedly positive impact on the above, however, 
the ability to continuously check real-time IG levels led 
to a degree of anxiety and stress when IG readings were 
less than 4 mmol/L despite her being oligosymptomatic 
or asymptomatic on most occasions. The patient was 
very keen to receive inpatient care despite reassurances 
that she could safely be discharged. She had a complex 
social and psychological background, which caused 
additional distress during her admission. This led to a 
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perceived dependence on midwifery staff. She used the 
data from FL as evidence that she was still having episodes 
of hypoglycaemia and leverage to extend her admission. 
We would therefore advise caution in CGM usage in 
individuals where excessive data may cause additional 
distress.
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